
Ask a doctor about a prescription for OLMESARTAN/HYDROCHLOROTHIAZIDE PENSA PHARMA 20 mg/12.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Olmesartan / Hydrochlorothiazide Pensa Pharma 20 mg / 12.5 mg film-coated tablets EFG
Olmesartan medoxomil / Hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
If you have any further questions, ask your doctor or pharmacist.
Contents of the package leaflet
Olmesartan / Hydrochlorothiazide Pensa Pharma contains two active substances, olmesartan medoxomil and hydrochlorothiazide, which are used to treat high blood pressure (hypertension):
? Olmesartan medoxomil belongs to a group of medicines called angiotensin II receptor antagonists. It lowers blood pressure by relaxing blood vessels.
? Hydrochlorothiazide belongs to a group of medicines called thiazide diuretics.
It lowers blood pressure by helping the kidneys to remove excess fluid from the body, increasing urine production.
Olmesartan / Hydrochlorothiazide will only be given if treatment with olmesartan alone has not controlled your blood pressure adequately. The combination of the two active substances in Olmesartan / Hydrochlorothiazide Pensa Pharma helps to lower blood pressure more than either substance on its own.
You may already be taking medicines to treat high blood pressure, but your doctor may think it is necessary for you to take olmesartan / hydrochlorothiazide to lower it further.
High blood pressure can be controlled with medicines such as Olmesartan / Hydrochlorothiazide Pensa Pharma. Your doctor may also have recommended that you make some changes to your lifestyle to help lower your blood pressure (e.g. lose weight, stop smoking, reduce alcohol consumption and reduce the amount of salt in your diet). Your doctor may also have recommended that you exercise regularly, such as walking or swimming. It is important to follow your doctor's advice.
Do not take Olmesartan / Hydrochlorothiazide Pensa Pharma:
If you think any of these apply to you, or if you are not sure, do not take the tablets. Talk to your doctor and follow their advice.
Warnings and precautions:
Tell your doctor before you start taking Olmesartan / Hydrochlorothiazide Pensa Pharma.
Before taking the tablets, tell your doctorif you are taking any of the following medicines for high blood pressure (hypertension):
Your doctor may check your kidney function, blood pressure, and blood electrolyte levels (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Olmesartan / Hydrochlorothiazide Pensa Pharma”.
Before taking the tablets, tell your doctorif you have any of the following health problems:
Tell your doctor if you experience any of the following symptoms:
Talk to your doctor if you experience abdominal pain, nausea, vomiting, or diarrhoea after taking Olmesartan/Hydrochlorothiazide Pensa Pharma. Your doctor will decide whether to continue treatment. Do not stop taking Olmesartan/Hydrochlorothiazide Pensa Pharma on your own.
Your doctor may want to see you more often and perform some tests if you have any of these problems.
Olmesartan / Hydrochlorothiazide Pensa Pharma may cause an increase in blood fat and uric acid levels (which can cause gout - painful swelling of the joints). Your doctor will probably want to perform a blood test from time to time to monitor these possible changes.
A change in blood levels of certain chemicals called electrolytes may occur. Your doctor will probably want to perform a blood test from time to time to monitor this possible change. Some signs of electrolyte changes are: thirst, dry mouth, muscle pain or cramps, tired muscles, low blood pressure (hypotension), feeling of weakness, slowness, tiredness, drowsiness or restlessness, nausea, vomiting, decreased need to urinate, rapid heart rate. Tell your doctor if you notice any of these symptoms.
As with any other medicine that lowers blood pressure, an excessive drop in blood pressure in patients with impaired blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
If you are going to have parathyroid function tests, you should stop taking Olmesartan / Hydrochlorothiazide Pensa Pharma before these tests are performed.
Athletes are informed that this medicine contains a component that may result in a positive doping test.
You must tell your doctor if you are pregnant or think you might be pregnant. Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended during pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken after this time (see section Pregnancy).
Children and adolescents:
Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended for children and adolescents under 18 years of age.
Using Olmesartan / Hydrochlorothiazide Pensa Pharma with other medicines:
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
In particular, tell your doctor or pharmacist if you are using any of the following medicines:
Your doctor may need to change your dose and/or take other precautions:
If you are taking an ACE inhibitor or aliskiren (see also the information under the headings “Do not take Olmesartan / Hydrochlorothiazide Pensa Pharma” and “Warnings and precautions”).
The level of lithium (a medicine used to treat mood changes and some types of depression) in the blood may increase if taken with olmesartan / hydrochlorothiazide, potentially leading to an increase in lithium toxicity. If you have to take lithium, your doctor will monitor your lithium blood levels.
Taking Olmesartan / Hydrochlorothiazide Pensa Pharma with food and drink
Olmesartan / Hydrochlorothiazide can be taken with or without food.
Be careful when drinking alcohol while taking olmesartan / hydrochlorothiazide, as some people feel weak or dizzy. If this happens, do not drink any alcohol, including wine, beer, or alcoholic drinks.
Black patients:
As with other similar medicines, the blood pressure-lowering effect of Olmesartan / Hydrochlorothiazide Pensa Pharma is somewhat less in black patients.
Pregnancy and breastfeeding:
Pregnancy
You must tell your doctor if you are pregnant or think you might be pregnant. Your doctor will normally advise you to stop taking Olmesartan / Hydrochlorothiazide Pensa Pharma before you become pregnant or as soon as you know you are pregnant, and will advise you to take a different medicine instead of Olmesartan / Hydrochlorothiazide Pensa Pharma. Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended during pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken after this time.
Breastfeeding
Tell your doctor if you are breastfeeding or about to start breastfeeding. Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended during breastfeeding, and your doctor will choose a different treatment for you if you want to breastfeed.
If you are pregnant or breastfeeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Use in athletes
Athletes are informed that this medicine contains a component (hydrochlorothiazide) that may result in a positive doping test.
Driving and using machines:
You may feel drowsy or dizzy while being treated for high blood pressure. If this happens, do not drive or use machines until the symptoms have gone away. Consult your doctor.
Information about excipients:
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Follow exactly the instructions of your doctor for taking this medicine. If you are not sure, consult your doctor or pharmacist again.
The recommended doseis one Olmesartan / Hydrochlorothiazide Pensa Pharma 20 mg/12.5 mg tablet per day. If your blood pressure is not controlled adequately, your doctor may change the dose to one Olmesartan / Hydrochlorothiazide Pensa Pharma 20 mg/25 mg tablet per day.
Take the tablets with water. If possible, take your dose at the same time each day, e.g. at breakfast time. It is important to continue taking Olmesartan / Hydrochlorothiazide Pensa Pharma until your doctor tells you to stop.
If you take more Olmesartan / Hydrochlorothiazide Pensa Pharma than you should:
If you take more tablets than you should or if a child accidentally takes one or more tablets, contact your doctor or go to the nearest hospital emergency department immediately and take the medicine pack with you.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service (tel. 91 562 04 20) stating the medicine and the amount taken.
If you forget to take Olmesartan / Hydrochlorothiazide Pensa Pharma:
If you forget to take a dose, take your normal dose the next day. Do not take a double dose to make up for forgotten doses.
If you stop taking Olmesartan / Hydrochlorothiazide Pensa Pharma:
It is important to continue taking olmesartan / hydrochlorothiazide unless your doctor tells you to stop.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
However, the following adverse effects can be serious:
Olmesartan / Hydrochlorothiazide Pensa Pharma is a combination of two active ingredients. The following information first describes the adverse effects reported so far with the olmesartan / hydrochlorothiazide combination (in addition to those already mentioned) and, secondly, the known adverse effects of the two active ingredients separately.
These are other known adverse effects so far withOlmesartan/ HydrochlorothiazidePensa Pharma:
If these effects occur, they are often mild and it is not necessary to interrupt treatment.
Common adverse effects (may affect up to 1 in 10 people):
Dizziness, weakness, headache, fatigue, chest pain, swelling of ankles, feet, legs, hands, or arms.
Uncommon adverse effects (may affect up to 1 in 100 people):
Rapid and intense heartbeat (palpitations), rash, eczema, vertigo, cough, indigestion, abdominal pain, nausea, vomiting, diarrhea, muscle cramps, and muscle pain, joint pain, arm and leg pain, back pain, erection problems in men, blood in urine.
Also, some changes in blood test results have been observed infrequently, including:
Increased levels of fat in the blood, increased urea or uric acid in the blood, increased creatinine, increased or decreased potassium levels in the blood, increased calcium levels in the blood, increased blood sugar, increased liver function test values. Your doctor will monitor you with a blood test and tell you if you need to take any action.
Rare adverse effects (may affect up to 1 in 1,000 people):
Feeling of discomfort, altered consciousness, skin swelling (hives), acute renal failure.
Also, some changes in blood test results have been observed rarely, including:
Increased blood urea nitrogen, decreased hemoglobin and hematocrit values. Your doctor will monitor you with a blood test and tell you if you need to take any action.
Additional adverse effects reported with the use of olmesartan medoxomil or hydrochlorothiazide alone, but not withOlmesartan/ HydrochlorothiazidePensa Pharmaor at a higher frequency:
Olmesartan medoxomil:
Common adverse effects (may affect up to 1 in 10 people):
Bronchitis, cough, nasal congestion and secretion, sore throat, abdominal pain, indigestion, diarrhea, nausea, gastroenteritis, joint or bone pain, back pain, blood in urine, urinary tract infection, flu-like symptoms, pain.
Also, some changes in blood test results have been observed frequently, including:
Increased levels of fat in the blood, increased urea or uric acid in the blood, increased liver or muscle function test values.
Uncommon adverse effects (may affect up to 1 in 100 people):
Rapid allergic reactions that can affect the whole body and cause breathing problems, as well as a rapid drop in blood pressure that can lead to fainting (anaphylactic reactions), facial inflammation, angina (chest pain or discomfort known as angina pectoris), feeling of discomfort, allergic skin rash, itching, exanthema (skin rash), skin swelling (hives).
Also, some changes in blood test results have been observed infrequently, including:
Reduction in the number of a type of blood cells called platelets (thrombocytopenia).
Rare adverse effects (may affect up to 1 in 1,000 people):
Renal function impairment, lack of energy.
Also, some changes in blood test results have been observed rarely, including:
Increased potassium in the blood.
Intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Hydrochlorothiazide:
Very common adverse effects (may affect more than 1 in 10 people):
Changes in blood tests, including: increased fat in the blood and increased uric acid levels.
Common adverse effects (may affect up to 1 in 10 people):
Feeling of confusion, abdominal pain, stomach discomfort, feeling of bloating, diarrhea, nausea, vomiting, constipation, glucose excretion in urine.
Also, some changes in blood test results have been observed, including:
Increased creatinine, urea, calcium, and blood sugar levels, decreased chloride, potassium, magnesium, and sodium levels in the blood. Increased serum amylase (hyperamylasemia).
Uncommon adverse effects (may affect up to 1 in 100 people):
Decreased or lost appetite, severe breathing difficulties, anaphylactic skin reactions (hypersensitivity reactions), worsening of pre-existing myopia, erythema, skin reactions due to light sensitivity, itching, purple spots or patches on the skin due to small hemorrhages (purpura), skin swelling (hives).
Rare adverse effects (may affect up to 1 in 1,000 people):
Inflammation and pain of the salivary glands, decreased number of white blood cells, decreased number of platelets in the blood, anemia, bone marrow depression, restlessness, depression, sleep problems, feeling of loss of interest (apathy), tingling and numbness, seizures (convulsions), yellowish perception of objects when looking at them, blurred vision, dry eyes, irregular heartbeat, inflammation of blood vessels, blood clots (thrombosis or embolism), lung inflammation, fluid accumulation in the lungs, pancreatitis, jaundice, infection in the gallbladder, lupus erythematosus symptoms such as skin rash, joint pain, and cold hands and fingers, allergic skin reactions, skin peeling and blisters, non-infectious kidney inflammation (interstitial nephritis), fever, muscle weakness (which can cause movement disorders).
Very rare adverse effects (may affect up to 1 in 10,000 people):
Electrolyte imbalance that can cause an abnormally reduced level of chloride in the blood (hypochloremic alkalosis), intestinal obstruction (paralytic ileus).
Acute respiratory distress (signs include severe respiratory difficulty, fever, weakness, and confusion).
Adverse effects of unknown frequency (cannot be estimated from available data):Decreased vision and eye pain due to elevated pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma], skin and lip cancer (non-melanoma skin cancer).
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiration date shown on the packaging and blister pack (after "CAD.:"). The expiration date is the last day of the month indicated.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition ofOlmesartán/ HydrochlorothiazidePensa Pharma
The active ingredient is olmesartan and hydrochlorothiazide. Each tablet contains 20 mg of olmesartan (as olmesartan medoxomil) and 12.5 mg of hydrochlorothiazide.
The other components are:
See section 2: information on excipients
Appearance of the product and package contents
Olmesartán / Hydrochlorothiazide Pensa Pharma 20 mg / 12.5 mg are yellow, cylindrical, biconvex film-coated tablets with the logo D1 on one side.
They are presented in aluminum-aluminum blister packs. Each pack contains 28 film-coated tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer:
Laboratorios Cinfa, S.A.
Olaz-Chipi, 10 - Polígono Industrial Areta 31620
Huarte-Pamplona, Spain
Date of the last revision of this prospectus:February 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products. http://www.aemps.gob.es
The average price of OLMESARTAN/HYDROCHLOROTHIAZIDE PENSA PHARMA 20 mg/12.5 mg FILM-COATED TABLETS in December, 2025 is around 10.1 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OLMESARTAN/HYDROCHLOROTHIAZIDE PENSA PHARMA 20 mg/12.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.